KLK3 and cancer: The low sensitivity of 20.5% for the subsequent PSA ≥ 4.1 ng/ml was likely attributed to the exclusion of men with a high initial PSA from the study4 and the failure to consider time since the last negative screening for interval cancers in non-biopsied men as disease-free.